RIAMET 20 mg/120 mg, tablet 24 tablets
Active ingredients: Artemether, Lumefantrine
Commercialized according to BDPMDispensing in France: Prescription only
Tablet24 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- RIAMET 20 mg/120 mg, comprimé
- Pharmaceutical form
- comprimé
- Route of administration
- orale
- Presentation description
- 4 plaquette(s) PVC polyéthylène PVDC aluminium de 6 comprimé(s)
- Marketing authorisation holder
- NOVARTIS PHARMA
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 21 Jul 2014
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65574434CIP72760330CIP133400927603303Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LUMÉFANTRINEcomprimé | 120 mg · un comprimé | SA |
| ARTÉMÉTHERcomprimé | 20 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.